(2021). Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metformin.
Chicago Style (17th ed.) CitationSimilar Cardiovascular Outcomes in Patients with Diabetes and Established or High Risk for Coronary Vascular Disease Treated with Dulaglutide with and Without Baseline Metformin. 2021.
MLA (8th ed.) CitationSimilar Cardiovascular Outcomes in Patients with Diabetes and Established or High Risk for Coronary Vascular Disease Treated with Dulaglutide with and Without Baseline Metformin. 2021.
Warning: These citations may not always be 100% accurate.